Global Botulinum Toxin Market Size To Reach USD 7.3 Billion By 2025

January 2017 | Report Format: Electronic (PDF)

The global botulinum toxin (BNT) market is expected to reach a value of USD 7.3 billion by 2025. The constant introduction of innovative products for enhancement of aesthetic appeal supporting minimally invasive aesthetic treatments is the prime factor driving the growth of the market. In addition, the rapid growth of the sector is attributed to the rising demand for minimally invasive or non-invasive procedures. These procedures provide advantages such as small incision, shorter hospital stay, and rapid wound healing, and hence lead to larger acceptance and demand. In addition, the availability of a wide variety of minimally invasive or non-invasive treatment options is pushing the global botulinum toxin market towards growth.

Also, the successful completion of research projects is expected to expand the applications of presently approved products. Companies are trying to widen the application of botulinum toxin in the therapeutic area through various research activities. For instance, Botox by Allergan received the U.S. FDA approval for the treatment of strabismus (crossed eyes) and blepharospasm associated with dystonia in 1989. Furthermore, in 2004, Botox was approved by the U.S. FDA for hyperidrosis, cervical dystonia, upper limb spasticity, chronic migraine, and urinary incontinence in 2009, 2010, and 2011 respectively. Hence, these factors all together will aid in boosting the growth of BNT sales during the forecast period.

 To request a sample copy or view summary of this report, click the link below:

Further Key Findings from the Study Suggest:

  • The rapid adoption of minimally invasive treatment is augmenting the growth of neurotoxins market.

  • The botulinum toxin type A segment accounted for the largest share in 2015 and is also anticipated to be the fastest-growing segment during the forecast period

  • In 2015, North America dominated the global space with the largest revenue share owing to the high demand for minimally invasive or non-invasive aesthetic treatments

  • Asia Pacific is expected to emerge as the fastest-growing region during the forecast period, mainly due to growing social awareness regarding anti-wrinkle procedures in India, China, and Japan

  • Major players competing in this market include but are not limited to Allergan, Inc.; Ipsen Group; Merz GmbH and Co. KGaA, Medytox, Inc.; US Worldmed, LLC; Lanzhou Institute of Biological Products. Co.Ltd. and Revance Therapeutics, Inc.

Grand View Research has segmented the botulinum toxin market by type, end use, and region:

Product Type Outlook (Revenue, USD Million; 2013 - 2025)

  • Botulinum Toxin Type A

  • Botulinum Toxin Type B

End-use Outlook (Revenue, USD Million; 2013 - 2025)

  • Therapeutic

  • Aesthetic

Regional Outlook (Revenue, USD Million; 2013 - 2025)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • The U.K.

  • Asia Pacific

    • China

    • Japan

  • Latin America

    • Mexico

    • Brazil

  • MEA

    • South Africa

Request Sample
Request for Customization

Pricing & Purchase Options

Buy Chapters or Sections

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA

Related Market Research